SEC Form 4 · accession 0001209191-18-038530
PROTEOSTASIS THERAPEUTICS, INC. · PTI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric Rabinowitz
Director
Period of report
Jun 15, 2018
Accepted (ET)
Jun 19, 2018 · 4:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001445283
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $3.19 | Jun 15, 2018 | A | 45,900 | A | — | Jun 15, 2028 | Common Stock | 45,900 | 45,900 | D |
Explanation of responses
- F1These securities shall vest and become exercisable in equal quarterly installments starting on June 15, 2018 until the option is fully vested and exercisable on June 15, 2019, subject to continued service.